annb0t
Top 20
Immutep Limited
Media Release
Expanding INSIGHT-003 trial evaluating efti with standard-of-care combination of anti-PD-1 therapy and chemotherapy to 50 patients Expansion based on safety and strong initial efficacy results Data updates expected throughout CY2023 and cost-efficient approach through investigator-initiated trial will further inform options related to 1L NSCLC development Clinical data to date shows efti uniquely positioned to address entire NSCLC patient population through both c...
>>> Read more: Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer
Media Release
Expanding INSIGHT-003 trial evaluating efti with standard-of-care combination of anti-PD-1 therapy and chemotherapy to 50 patients Expansion based on safety and strong initial efficacy results Data updates expected throughout CY2023 and cost-efficient approach through investigator-initiated trial will further inform options related to 1L NSCLC development Clinical data to date shows efti uniquely positioned to address entire NSCLC patient population through both c...
>>> Read more: Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer
